Genmab Expands ADC Pipeline with $1.8 Billion Acquisition of ProfoundBio April 4, 2024 AutoBot News 0 Genmab’s acquisition of ProfoundBio will boost its clinical and preclinical pipeline of ADCs for targeted cancer treatment.